CL2008003304A1 - Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae. - Google Patents

Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae.

Info

Publication number
CL2008003304A1
CL2008003304A1 CL2008003304A CL2008003304A CL2008003304A1 CL 2008003304 A1 CL2008003304 A1 CL 2008003304A1 CL 2008003304 A CL2008003304 A CL 2008003304A CL 2008003304 A CL2008003304 A CL 2008003304A CL 2008003304 A1 CL2008003304 A1 CL 2008003304A1
Authority
CL
Chile
Prior art keywords
mycoplasma hyopneumoniae
eliciting
animal
immune response
immunogenic composition
Prior art date
Application number
CL2008003304A
Other languages
English (en)
Inventor
Wumin Li
Zhichang Xu
Hsien-Jue Chu
Nicole Rae Gibson
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of CL2008003304A1 publication Critical patent/CL2008003304A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CL2008003304A 2007-11-06 2008-11-06 Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae. CL2008003304A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98581107P 2007-11-06 2007-11-06

Publications (1)

Publication Number Publication Date
CL2008003304A1 true CL2008003304A1 (es) 2009-01-09

Family

ID=40303616

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003304A CL2008003304A1 (es) 2007-11-06 2008-11-06 Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae.

Country Status (20)

Country Link
US (1) US9056909B2 (es)
EP (1) EP2217271B1 (es)
JP (1) JP5869221B2 (es)
KR (1) KR101225304B1 (es)
CN (2) CN101883581A (es)
AR (1) AR069216A1 (es)
AU (1) AU2008324780A1 (es)
BR (1) BRPI0820341B1 (es)
CA (1) CA2704775C (es)
CL (1) CL2008003304A1 (es)
CO (1) CO6270337A2 (es)
DK (1) DK2217271T3 (es)
HK (1) HK1198289A1 (es)
ME (1) ME01000B (es)
MX (1) MX2010005014A (es)
RU (1) RU2489164C9 (es)
TW (1) TWI513463B (es)
UA (1) UA98812C2 (es)
WO (1) WO2009061798A1 (es)
ZA (1) ZA201004026B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
PE20120909A1 (es) * 2009-05-19 2012-08-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma
EA201291175A1 (ru) * 2010-05-19 2013-06-28 Байопропертис Пти Лтд. Способы, относящиеся к аттенуированной микоплазме
WO2013131565A1 (en) 2012-03-07 2013-09-12 Ceva Sante Animale Novel veterinary vaccine
CN105327344B (zh) * 2011-08-01 2019-03-05 普莱柯生物工程股份有限公司 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
CN103157100B (zh) * 2011-12-08 2014-09-24 普莱柯生物工程股份有限公司 副猪嗜血杆菌病、猪链球菌病二联灭活疫苗及其制备方法
CN103157104B (zh) * 2011-12-14 2015-11-18 普莱柯生物工程股份有限公司 猪瘟疫苗的硫代硫酸钠稀释液
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
EP2684959A1 (en) * 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN103623400B (zh) * 2012-08-24 2016-08-17 普莱柯生物工程股份有限公司 抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
CN103861095B (zh) * 2012-12-11 2016-03-09 普莱柯生物工程股份有限公司 含猪支原体肺炎抗原和猪链球菌病抗原的疫苗组合物及其制备方法和应用
MX361273B (es) * 2012-12-28 2018-12-03 Boehringer Ingelheim Vetmedica Gmbh Metodo para obtener una vacuna de mycoplasma.
EA038206B1 (ru) 2012-12-28 2021-07-23 Бёрингер Ингельхайм Ветмедика Гмбх Иммуногенная композиция, содержащая антигены микоплазм
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
CN104338128B (zh) * 2013-07-31 2017-09-05 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN109078179A (zh) * 2013-09-05 2018-12-25 硕腾服务有限责任公司 Hendra和Nipah病毒G糖蛋白免疫原性组合物
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10279031B2 (en) * 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
US10519199B2 (en) * 2016-08-12 2019-12-31 Innovac Vaccine composition comprising recombinant protein for preventing swine Mycoplasma infection
CN109234418B (zh) * 2018-11-20 2021-08-13 湖南中净生物科技有限公司 一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112143666B (zh) * 2020-09-07 2023-02-21 华中农业大学 一种猪肺炎支原体弱毒株及其在制备弱毒疫苗中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917619A (en) 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
JPS5540568B2 (es) * 1972-10-05 1980-10-18
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
FR2565825B1 (fr) 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
JPS62273456A (ja) 1986-05-21 1987-11-27 Tosoh Corp 分析装置用に用いるテストカツプのシ−ル箔破開用シ−ルブレ−カ
JPH0795069B2 (ja) * 1986-05-22 1995-10-11 農林水産省家畜衛生試験場長 マウスＩｇＡ単クローン抗体を用いる豚マイコプラズマ肺炎の診断方法
EP0283840A3 (en) 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0571648A1 (en) 1992-05-26 1993-12-01 Chung-Nan Weng Vaccine protecting against mycoplasmal pneumonia
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
ZA9710606B (en) * 1996-12-05 1998-06-12 Akzo Nobel Nv Non-virulent Mycoplasma synoviae vaccine thereof.
JP2003513935A (ja) * 1999-11-08 2003-04-15 バイオミューン マイコプラズマ・ボビスに対するワクチンおよび使用方法
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
JP2004537543A (ja) * 2001-07-02 2004-12-16 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ・ワクチンおよび牛におけるマイコプラズマ・ボビス低減方法
BR0210804A (pt) 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
MXPA04000680A (es) 2001-07-27 2004-04-05 Wyeth Corp Vacuna para virus west nile.
US20030129161A1 (en) 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CA2481042A1 (en) * 2002-04-05 2003-10-23 Walter H. Hsu Mycoplasma polypeptides
TWI350174B (en) 2003-03-12 2011-10-11 Wyeth Corp Adjuvanted bovine vaccines
RU2278704C2 (ru) * 2004-01-12 2006-06-27 Алексей Борисович Башкиров Метод индукции иммунного ответа организма млекопитающих-2

Also Published As

Publication number Publication date
RU2010117614A (ru) 2011-12-20
UA98812C2 (ru) 2012-06-25
TWI513463B (zh) 2015-12-21
CA2704775C (en) 2016-05-10
KR20100087202A (ko) 2010-08-03
BRPI0820341B1 (pt) 2021-11-09
EP2217271A1 (en) 2010-08-18
EP2217271B1 (en) 2016-05-04
WO2009061798A1 (en) 2009-05-14
HK1198289A1 (en) 2015-03-27
CN101883581A (zh) 2010-11-10
DK2217271T3 (en) 2016-06-06
ZA201004026B (en) 2011-04-28
KR101225304B1 (ko) 2013-01-22
MX2010005014A (es) 2010-06-30
JP5869221B2 (ja) 2016-02-24
CA2704775A1 (en) 2009-05-14
AU2008324780A1 (en) 2009-05-14
US9056909B2 (en) 2015-06-16
JP2011503086A (ja) 2011-01-27
RU2489164C9 (ru) 2014-01-20
CN104043116A (zh) 2014-09-17
RU2489164C2 (ru) 2013-08-10
US20090117152A1 (en) 2009-05-07
BRPI0820341A2 (pt) 2020-05-19
TW200927166A (en) 2009-07-01
CO6270337A2 (es) 2011-04-20
ME01000B (me) 2012-10-20
AR069216A1 (es) 2010-01-06

Similar Documents

Publication Publication Date Title
CL2008003304A1 (es) Composicion inmunogenica para provocar una respuesta inmune anti-mycoplasma hyopneumoniae en un animal que comprende una cepa avirulenta viva de mycoplasma hyopneumoniae.
CR11122A (es) Vacuna de influenza de emulsion de aceite en agua
MX2010007815A (es) Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
DK2291195T4 (da) Vaccine til beskyttelse mod lawsonia intracellularis, mycoplasma hyopneumoniae og porcin circovirus
BRPI0812856A2 (pt) Composições de vacina de emulsão que compreendem antígeno e adjuvante na fase aquosa.
BR112015009541A2 (pt) novos adjuvantes de mucosa e sistemas de aplicação
CL2014002676A1 (es) Composicion inmunogenica trivalente que comprende mycoplasma hyopneumaniae (m. hyo), un antigeno del circovirus de tipo 2 (pcv2) y un antigeno del virus respiratorio y reproductivo porcino (srrp); procedimiento para inmunizar; procedimiento de preparacion de la composicion.
BRPI1015283A2 (pt) composições para tingimento de queratina que compreendem um eliminador de radicais e uso das mesmas.
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
BRPI0912263A2 (pt) composição de vacina, e, método para imunizar uma cobaia animal contra coccidiose
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
BRPI1007721A2 (pt) composição de vacina para induzir uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolada e método para induzir uma resposta imunológica para um rotavírus em um indivíduo
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
BR112015021523A8 (pt) composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
BR112015005056A2 (pt) vacinas de combinação com sorogrupo b meningococcus e d/t/p
IL254110A0 (en) An immunogenic preparation containing an immunogenic protein and a combination of substances that help to create antigen responses specific to the t cell
BRPI0915076A2 (pt) composições de vacina, composição imunogênica, método para expressão dos antígenos quiméricos de hpv-hbsag supramencionados, composição farmacêutica, método para ocasionar resposta de anticorpo protetor para composição antigênica e/ou resposta de célula t citotóxica, uso das formulações antigênicas supramencionadas.
BRPI0808037A2 (pt) Preparação liofilizada contendo vacina contra gripe e método para preparação da mesma.
BRPI0620693A2 (pt) método para suscitar uma resposta imune tanto sistêmica como de mucosa a mycobacteria viva atenuada ou antígenos micobacterianos em um hospedeiro
BR112019004303A2 (pt) composição de conjugados multivalentes de polissacarídeo capsular pneumocócico-proteína portadora e uso da mesma
AR063882A1 (es) Vacuna canina leishmania
BRPI0918226A2 (pt) composição imunogênica, método para produzir uma composição imunogênica, método para elicitar uma resposta imune contra neisseria, uso da composição imunogênica, e, vacina
EP2162151A4 (en) CLASSIC ATTENUATED LIVING VACCINE AGAINST ANTIGENICALLY MARKED SWINE FEVER
BRPI0815846A2 (pt) método para reforçar a imunogenicidade de uma vacina em um indivíduo.